Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor...

Area of Science:

• Molecular Biology
• Cellular Biology
• Gene Regulation

Background:

• DEC1 and DEC2 are bHLH transcription factors involved in cellular processes.
• Hypoxia up-regulates DEC1 and DEC2 expression, but their functions remain unclear.
• Vascular Endothelial Growth Factor (VEGF) expression is hypoxia-inducible via HIF-1alpha and ARNT1.

Purpose of the Study:

• To elucidate the functions of DEC1 and DEC2 under hypoxic conditions.
• To investigate the role of DEC2 in regulating VEGF gene expression.
• To determine the interaction between DEC2, HIF-1alpha, and VEGF regulation.

Main Methods:

• Co-immunoprecipitation assays to assess protein interactions.
• Analysis of VEGF promoter activity and HIF-1alpha binding under varying DEC2 expression levels.
• Investigation of circadian expression patterns of DEC2 and VEGF in cartilage and tumor cells.

Main Results:

• DEC2, but not DEC1, suppressed VEGF gene expression under hypoxia.
• DEC2 protein co-immunoprecipitated with HIF-1alpha, but not ARNT1.
• DEC2 overexpression decreased HIF-1alpha binding to the VEGF promoter's HRE, while knockdown increased it.
• Circadian expression of VEGF was inversely correlated with DEC2 in cartilage.
• DEC2 exhibited circadian oscillation in Sarcoma 180 cells.

Conclusions:

• DEC2 acts as a negative regulator of VEGF expression.
• DEC2 plays a significant role in pathological conditions involving VEGF.
• The interaction between DEC2 and HIF-1alpha is critical for controlling VEGF levels during hypoxia.